Question 1

What is the catalog number for Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134)?

Accepted Answer

The catalog number for Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) is A2914-1mg*5.

Question 2

What sizes are available for Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134)?

Accepted Answer

Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) is available in the following size(s): 5x 1mg.

Question 3

Is Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) in stock?

Accepted Answer

Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Who manufactures Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134)?

Accepted Answer

Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) is manufactured by Bimake.

Question 5

What is the estimated delivery time for Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134)?

Accepted Answer

Estimated delivery time for Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) is approximately 15 business day(s), depending on your location.

Question 6

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 7

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 8

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134)

Product Specifications

CAS Number

Target

Applications

Additionnal Information

Storage Conditions

Frequently Asked Questions

Explore Other Products

CD47 (B6H12.2), CF740 conjugate, 0.1mg/mL

HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF488A conjugate, 0.1mg/mL

MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF740 conjugate, 0.1mg/mL

TGF-beta (1D11.16.8), CF568 conjugate, 0.1mg/mL

SOX9 / SRY-box 9 (SOX9/2387), CF568 conjugate, 0.1mg/mL

GLUT-1 (Tumor Progression and Mesothelioma Marker) (GLUT1/2475), CF405S conjugate, 0.1mg/mL